Indeed, AD pathology seems to be mediated, at least partly, by the dysregulation of this pathway that allows GSK3 overactivation, which consequently causes tau hyperphosphorylation [181,182,183] (Figure 7 (12)). The gene discussed is MAPT; the disease is Alzheimer disease.